Looks like a great short to $30 on this horrible news.
Lannett Company, Inc. (NYSE: LCI) today announced that it has received interrogatories and subpoena from the State of Connecticut Office of the Attorney General concerning its investigation into pricing of digoxin. According to the subpoena, the Connecticut Attorney General is investigating whether anyone engaged in any activities that resulted in (a) fixing, maintaining or controlling prices of digoxin or (b) allocating and dividing customers or territories relating to the sale of digoxin in violation of Connecticut antitrust law. The Company maintains that it acted in compliance with all applicable laws and regulations and intends to cooperate with the Connecticut Attorney General’s investigation.
Where there smoke, there fire!
Reynolds American (NYSE: RAI) deal to acquire Lorillard (NYSE: LO) has a $740 million termination fee, according to SEC filings
BAT owned about 42 percent of Reynolds, and has agreed to buy around $4.7 billion of extra shares to help finance the purchase of Lorillard, and to retain an equivalent level of ownership in the resulting company. But BAT recently rolled out Vype, a e-cig brand in the United Kingdom.
This deal is as good a s done.
Reynolds and Lorillard value the deal at about $27 billion including debt. It is expected to close in the first half of 2015 but will likely face regulatory scrutiny. Lorillard shareholders would receive $50.50 in cash for each share and 0.2909 of a share in Reynolds stock at closing, a combination valued by the companies at $68.88 per share.
Again if u were RAI share holder would u approve this deal? Hell no!
Right now the market is telling u that RAi share holder should not/will approve this deal. Good luck
Where are all the pumpers go? Crawling back into their parents basement? Lol...Keep buying boys!
Come on bag holders get in there & buy, buy, buy. Lol See you at $2, then $1, then?
Lol... Keep buying all the way to ZERO......
JPMorgan Chase beats by $0.30, beats on revenue
JPMorgan Chase (NYSE:JPM): Q2 EPS of $1.59 beats by $0.30.
Revenue of $25.3B (-2.5% Y/Y) beats by $1.54B.
Q2 earnings of $6B or $1.46 per share includes $500M or $0.13 per share in after-tax legal expense. Estimates were for earnings of $1.31 per share. About $3B returned to shareholders - $1.5B stock buyback and $0.40 dividend.
Consumer & Community Banking net income of $2.4B fallsl 21% Y/Y, with net revenue of $11.4B off 5%. Net interest income of $7B falls 2%. Noninterest revenue of $4.5B down 9% thanks to mortgage slowdown (originations fell 66% from a year ago). Credit loss provision of $852M compared with a benefit of $19M a year ago. Noninterest expense of $6.5B falls 6% driven by job cuts in mortgages.
Corporate & Investment Bank net income of $2B fallsl 25% Y/Y on revenue of $9B, off 6% (excluding impact of DVA). Banking revenue of $3.1B off 2%, with higher advisory fees and equity underwriting fees offset by lower debt underwriting fees. Markets & Investor Services revenue of $5.9B falls 12%, with fixed income revenue of $3.5B off 15%.
WTO judges have ruled the U.S. imposition of tariffs on Chinese solar modules, steel products, and other exports violates global trade rules.
Though rejecting some Chinese arguments against U.S. tariffs, the judges ultimately ruled the tariffs are inconsistent with obligations under the 1994 Marrakesh accord.
The U.S. originally imposed tariffs on Chinese solar module exports in 2012, and followed up last month by slapping new preliminary tariffs meant to close a loophole related to the use of non-Chinese cells.